한글목차

세계의 골수 이식 시장 규모는 2025년에는 112억 달러로 추정되고, 2032년에는 152억 6,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 4.5%로 성장할 전망입니다.

그림. 골수이식 시장 지역별 점유율(%)(2025년)

골수 이식은 환자의 손상된 골수 또는 건강에 해로운 골수 대신 건강한 골수 줄기 세포를 주입하는 치료입니다. 골수 이식은 백혈병, 림프종, 기타 혈액 질환 등 다양한 혈액암의 치료에 일반적으로 사용되고 있습니다. 줄기세포는 환자로부터 채취하는 방법(자가이식)과 기증자로부터 채취하는 방법(동종이식)이 있습니다. 동종이식은 제공된 줄기세포가 건강한 새로운 세포를 생성할 수 있기 때문에 자가이식에 비해 성공률이 높습니다. 그러나 면역 거부 반응으로 인한 합병증의 위험도 높아집니다. 이식 수술의 진보와 기증자와의 매칭 개선으로 골수 이식에 대한 수요가 매우 높아지고 있습니다.

시장 역학 :

세계의 골수 이식 시장의 성장을 견인하고 있는 것은 세계에서 혈액암이나 기타 혈액 질환의 유병률이 상승하고 있는 것입니다. WHO가 발표한 데이터에 따르면 2018년에는 세계에서 약 1,810만 명의 새로운 암 환자와 960만 명의 암 사망자가 보고되었습니다. 게다가 효과적인 대체치료로서의 이식에 대한 의식 증가와 면역억제제의 연구개발에 대한 투자 증가가 시장개척을 뒷받침하고 있습니다. 그러나 이식 수술과 관련된 고가의 비용, 적합 기증자의 제한된 가용성, 이식 후 이식편 거부 반응의 위험이 시장 성장을 방해할 수 있습니다. 또한, 골수의 대체요법으로서 말초혈 줄기세포가 채용되고 있는 것도, 시장 성장의 방해가 되고 있습니다. 줄기 세포 치료의 개발은 가까운 미래에 시장 진출자에게 유리한 기회를 제공할 수 있습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 골수이식 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
• 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계 골수 이식 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• 세계의 골수이식 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
• 이해관계자들은 세계의 골수이식 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적 및 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수 및 제휴 시나리오
• 자금 조달 및 투자
• PEST 분석
• Porter's Five Forces 분석

제4장 세계의 골수 이식 시장 : COVID-19 팬데믹의 영향

• 전체적인 영향
• 정부의 대처
• 시장에 대한 COVID-19의 영향

제5장 세계의 골수 이식 시장 : 유형별(2020-2032년)

• 자가이식
• 동종이식
• 기타

제6장 세계의 골수 이식 시장 : 치료 유형별(2020-2032년)

• 백혈병
• 림프종
• 골수종
• 골수이형성증후군
• 골수증식성 질환
• 재생 불량성 빈혈
• 고형 종양
• 겸상 적혈구 빈혈
• 사라 세미아
• 기타

제7장 세계의 골수 이식 시장 : 최종 사용자별(2020-2032년)

• 병원
• 다진료과 클리닉
• 외래수술센터(ASC)

제8장 세계의 골수 이식 시장 : 지역별(2020-2032년)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 프로파일
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • AllCells LLC.
  • STEMCELL Technologies
  • ATCC Inc.
  • Hemacare Corporation
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.
  • Actinium Pharmaceuticals, Inc
  • Bluebird Bio, Inc
  • Gilead Sciences, Inc
  • Novartis AG

제10장 분석가 추천

• 운명의 원
• 애널리스트의 견해
• Coherent Opportunity Map(COM)

제11장 참고문헌 및 조사방법

• 참고문헌
• 조사방법

영문목차

Global Bone Marrow Transplant Market is estimated to be valued at USD 11.20 Bn in 2025 and is expected to reach USD 15.26 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.

Figure. Bone Marrow Transplant Market Share (%), By Region 2025

Bone marrow transplant is a procedure that infuses healthy bone marrow stem cells to replace the damaged or unhealthy bone marrow of a patient. It is commonly used for treating various blood cancers like leukemia, lymphoma and other blood disorders. The stem cells can either be obtained from the patient (autologous transplant) or from a donor (allogeneic transplant). Allogeneic transplants have shown more success rates as compared to autologous as the donated stem cells can produce healthy new cells. However, it also carries higher risks of complications due to immune rejection. With advancements in transplant procedures and better donor matching, there has been huge demand for bone marrow transplants.

Market Dynamics:

Global bone marrow transplant market growth is driven by rising prevalence of blood cancers and other hematological disorders worldwide. According to the data published by WHO, around 18.1 million new cancer cases and 9.6 million cancer deaths were reported in 2018 globally. Furthermore, growing awareness about transplantation as an effective treatment alternative and increasing investment in research & development of immunosuppressant drugs are driving the market growth. However, high costs associated with transplant procedures, limited availability of matched donors, and risks of graft rejection post-transplant can hamper the market growth. Adoption of peripheral blood stem cells as an alternative to bone marrow can also hamper the market growth. The development of stem cell therapies can offer lucrative opportunities for market players in the near future.

Key Features of the Study:

• This report provides in-depth analysis of the global bone marrow transplant market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bone marrow transplant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AllCells, ReachBio LLC, Conversant Bio, Cellular Dynamics International, and Takeda Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bone marrow transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone marrow transplant market

Detailed Segmentation-

• By Type
  • Autologous Transplant
  • Allogenic Transplant
  • Others
• By Treatment Type
  • Leukemia
  • Lymphoma
  • Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Disorders
  • Aplastic Anemia
  • Solid Tumors
  • Sickle cell Anemia
  • Thalassemia
  • Others
• By End User
  • Hospitals
  • Multi-specialty Clinics
  • Ambulatory Surgical Centers
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • AllCells LLC.
  • STEMCELL Technologies
  • ATCC Inc.
  • Hemacare Corporation
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.
  • Actinium Pharmaceuticals, Inc
  • Bluebird Bio, Inc
  • Gilead Sciences, Inc
  • Novartis AG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Bone Marrow Transplant Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Bone Marrow Transplant Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Autologous Transplant
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Allogenic Transplant
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Bone Marrow Transplant Market, By Treatment Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Leukemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Lymphoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Myeloma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Myelodysplastic Syndrome
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Myeloproliferative Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Aplastic Anemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Solid Tumors
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sickle cell Anemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Thalassemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Bone Marrow Transplant Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multi-specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Bone Marrow Transplant Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Merck Millipore Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi-Aventis LLC.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AllCells LLC.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • STEMCELL Technologies
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ATCC Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hemacare Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.
  • Actinium Pharmaceuticals, Inc
  • Bluebird Bio, Inc
  • Gilead Sciences, Inc
  • Novartis AG

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact

"